MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: U.S. Federal
*Funding: HHS
*HHS: Contracts, Contractors & Awards
*BARDA: Contracts (IDIQ, GWACS, Etc.), Contractors & Awardees
*Contractors & Awardees: BARDA
Senzo Health
Organization & Developments: Senzo Health
Parents
Senzo Health
Children
2022: Senzo Receives Funding From the Biomedical Advanced Research and Development Authority (BARDA) to Advance Its PCR-Accurate Lateral Flow COVID-19 Test
2022: Senzo Secures a $2mm Pre-Series A Financing Led by Bioadvance to Progress Its Breakthrough Lateral Flow Diagnostic Testing Platform for Covid-19, Flu A/B, Tuberculosis, HIV
2022: With Fresh Funding, Senzo Looks Ahead to a New Era of Point-Of-Care Diagnostics and Growth in Philadelphia_biobuzz
Amplified Lateral Flow (ALF) diagnostics
Senzo Health has developed a lateral flow test which delivers the same accuracy as laboratory-based PCR, with results available within 10 minutes, at a fraction of the cost.
Senzo is an in vitro diagnostics company developing innovative, accurate, and accessible testing products.
Jumps
Finance & Acquisitions: Senzo Health
Key People: Senzo Health